Role for protease activity in visceral pain in irritable bowel syndrome

Cenac, Nicolas, Andrews, Christopher N., Holzhausen, Marinella, Chapman, Kevin, Cottrell, Graeme, Andrade-Gordon, Patricia, Steinhoff, Martin, Barbara, Giovanni, Beck, Paul, Bunnett, Nigel W., Sharkey, Keith A., Ferraz, Jose Geraldo P., Shaffer, Eldon, Vergnolle, Nathalie·2007·Journal of Clinical Investigation
DOI 10.1172/jci29255

Cited by (591)

Items 101–200 of 591

  1. Microflora Modulation of Motility
    Eamonn M.M. Quigley · 2011 · Journal of Neurogastroenterology and Motility
  2. Protease-activated receptor-2 activation: a major actor in intestinal inflammation
    Eric Hyun, Patricia Andrade‐Gordon, Martin S. Steinhoff, Nathalie Vergnolle · 2008 · Gut
  3. Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice
    Gintautas Grabauskas, Xiaoyin Wu, Jun Gao, Jiyao Li, Danielle Kim Turgeon, Chung Owyang · 2020 · Gastroenterology
  4. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome
    William Lee Hasler, Gintautas Grabauskas, Prashant Singh, Chung Owyang · 2022 · Neurogastroenterology & Motility
  5. Immune activation in irritable bowel syndrome: what is the evidence?
    Javier Aguilera‐Lizarraga, Hind Hussein, Guy E. Boeckxstaens · 2022 · Nature reviews. Immunology
  6. Randomised controlled trial of mesalazine in IBS
    Giovanni Barbara, Cesare Cremon, Vito Annese, Guido Basilisco, Franco Bazzoli, Massimo Bellini, A. Benedetti, L. Benini, Fabrizio Bossa, P. Buldrini et al. · 2014 · Gut
  7. Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome
    Edwinson, Adam L., Yang, Lu, Peters, Stephanie, Hanning, Nikita, Jeraldo, Patricio, Jagtap, Pratik, Simpson, Joshua B., Yang, Tzu-Yi, Kumar, Praveen, Mehta, Subina et al. · 2022 · Nature Microbiology
  8. Serine proteases and protease-activated receptor 2-dependent allodynia: A novel cancer pain pathway
    David K. Lam, Brian L. Schmidt · 2010 · Pain
  9. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
    Edogawa, Shoko, Edwinson, Adam L, Peters, Stephanie A, Chikkamenahalli, Lakshmikanth L, Sundt, Wendy, Graves, Sara, Gurunathan, Sakteesh V, Breen-Lyles, Margaret, Johnson, Stephen, Dyer, Roy et al. · 2020 · Gut
  10. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis
    Caterina Carco, Wayne Young, Richard Blair Gearry, Nicholas J. Talley, Warren Charles McNabb, Nicole Clemence Roy · 2020 · Frontiers in Cellular and Infection Microbiology
  11. Protease‐activated receptor‐4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity
    Augé, C., Balz‐hara, D., Steinhoff, M., Vergnolle, N., Cenac, N. · 2009 · Neurogastroenterology & Motility
  12. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
    Alain P. Gobert, Giulia Sagrestani, Eve Delmas, Keith T. Wilson, Thomas G. Verriere, Michel C. Dapoigny, Christophe Del’Homme, Annick Bernalier‐Donadille · 2016 · Scientific Reports
  13. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease
    Isabelle Cleynen, Emilie Vazeille, Marta Artieda, Hein W. Verspaget, Magdalena Szczypiorska, Marie-Agnès Bringer, Peter Laszlo Lakatos, Frank Seibold, Kirstie S. Parnell, Rinse Karel Weersma et al. · 2013 · Gut
  14. Gastrointestinal roles for proteinase‐activated receptors in health and disease
    Atsufumi Kawabata, M Matsunami, Fumiko Sekiguchi · 2007 · British Journal of Pharmacology
  15. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine
    Angèle P. M. Kerckhoffs, J. J. M. Ter Linde, Louis M. A. Akkermans, Melvin Samsom · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  16. Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndrome
    Christopher N. Andrews, Tanya A. M. Griffiths, Jaime Kaufman, Nathalie Vergnolle, Michael Gordon Surette, Kevin P. Rioux · 2011 · Alimentary Pharmacology & Therapeutics
  17. The Role of the FODMAP Diet in IBS
    Luisa Bertin, Miriana Zanconato, Martina Crepaldi, Giovanni Marasco, Cesare Cremon, Giovanni Barbara, Brigida Barberio, Fabiana Zingone, Edoardo Vincenzo Savarino · 2024 · Nutrients
  18. Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?
    Braak, Breg, Klooker, Tamira K, Wouters, Mira M, Welting, Olaf, van der Loos, Chris M, Stanisor, Oana I, van Diest, Sophie, van den Wijngaard, Rene M, Boeckxstaens, Guy E · 2012 · American Journal of Gastroenterology
  19. Stress-Related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study
    Muriel H. Larauche, Agata Mulak, Yvette Taché · 2011 · Journal of Neurogastroenterology and Motility
  20. Brain–Gut Interactions Increase Peripheral Nociceptive Signaling in Mice With Postinfectious Irritable Bowel Syndrome
    Charles O. Ibeakanma, Fernando Ochoa‐Cortés, Marcela Miranda‐Morales, Todd G. McDonald, Ian Spreadbury, Nicolas Cénac, Fiore Cattaruzza, David J. Hurlbut, Stephanie Vanner, Nigel W. Bunnett et al. · 2011 · Gastroenterology
  21. Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease
    Denadai-Souza, Alexandre, Bonnart, Chrystelle, Tapias, Núria Solà, Marcellin, Marlène, Gilmore, Brendan, Alric, Laurent, Bonnet, Delphine, Burlet-Schiltz, Odile, Hollenberg, Morley D., Vergnolle, Nathalie et al. · 2018 · Scientific Reports
  22. TRP channels in neurogastroenterology: opportunities for therapeutic intervention
    Werend Boesmans, Grzegorz Owsianik, Jan F. Tack, Thomas Voets, Pieter Vanden Berghe · 2010 · British Journal of Pharmacology
  23. Plasticity of enteric nerve functions in the inflamed and postinflamed gut
    Gary M. Mawe, Derek S. Strong, Keith A. Sharkey · 2009 · Neurogastroenterology & Motility
  24. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
    D. Tooth, K. Garsed, Gulzar Singh, L. Marciani, C. Lam, I. Fordham, A. Fields, R. Banwait, M. Lingaya, R. Layfield et al. · 2013 · Gut
  25. The emerging roles of bacterial proteases in intestinal diseases
    Caminero, Alberto, Guzman, Mabel, Libertucci, Josie, Lomax, Alan E. · 2023 · Gut Microbes
  26. Panic Disorder Comorbidity with Medical Conditions and Treatment Implications
    Alicia E. Meuret, Juliet L. Kroll, Thomas Ritz · 2017 · Annual Review of Clinical Psychology
  27. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS
    Eluisa Perna, Javier Aguilera‐Lizarraga, Morgane V. Florens, Piyush Jain, Stavroula Theofanous, Nikita Hanning, Joris G. De Man, Maya Berg, Benedicte Y. De Winter, Yeranddy Aguiar Alpizar et al. · 2020 · Gut
  28. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents
    Ayesha Akbar, Julian R.F. Walters, Subrata K. Ghosh · 2009 · Alimentary Pharmacology & Therapeutics
  29. Neuroimmune Interactions in the Intestine
    Antonia Wallrapp, Isaac M. Chiu · 2024 · Annual Review of Immunology
  30. Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Mei‐Kwan Yau, Ligong Liu, David P. Fairlie · 2013 · Journal of Medicinal Chemistry
  31. Irritable bowel syndrome
    Nicholas J. Talley · 2006 · Internal Medicine Journal
  32. Food Intolerance: The Role of Histamine
    Yu. O. Shulpekova, V. M. Nechaev, I. R. Popova, Т. A. Deeva, Arthur Tigranovich Kopylov, Kristina Akhmedovna Malsagova, Anna L. Kaysheva, Vladimir T Ivashkin · 2021 · Nutrients
  33. The Role of Mast Cells in Irritable Bowel Syndrome
    Kang Nyeong Lee, Oh Young Lee · 2016 · Gastroenterology Research and Practice
  34. Molecular Mechanisms of TRPV4‐Mediated Neural Signaling
    Wolfgang Liedtke · 2008 · Annals of the New York Academy of Sciences
  35. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients
    Angèle P. M. Kerckhoffs, J. J. M. Ter Linde, Louis M. A. Akkermans, Melvin Samsom · 2008 · Neurogastroenterology & Motility
  36. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications
    Ian M. Carroll · 2013 · World Journal of Gastroenterology
  37. Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments
    Alexander Charles Ford, Stephen J. Vanner, Purna Kashyap, Yasmin Nasser · 2024 · Gastroenterology
  38. Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome
    Giovanni Barbara, Lisa Zecchi, Maria Raffaella Barbaro, Cesare Cremon, Lara Bellacosa, Marco Marcello Marcellini, Roberto DE GIORGIO, Roberto Corinaldesi, Vincenzo Stanghellini · 2012 · Journal of Clinical Gastroenterology
  39. Probiotics in the Management of Functional Bowel Disorders
    Eamonn M.M. Quigley · 2012 · Gastroenterology Clinics of North America
  40. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016
    Peter Layer, Viola Andresen, H.‐D. Allescher, Stephan C. Bischoff, Martin Claßen, Sigrid Elsenbruch, M. Freitag, Thomas Frieling, Maximilian Gebhard, Miriam Goebel‐Stengel et al. · 2021 · Zeitschrift für Gastroenterologie
  41. Functions and Imaging of Mast Cell and Neural Axis of the Gut
    Michael Schemann, Michael Camilleri · 2013 · Gastroenterology
  42. Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: Influence of surgery and postoperative single housing on visceromotor responses
    Muriel H. Larauche, Guillaume Gourcerol, Mulugeta Million, David W. Adelson, Yvette Taché · 2010 · Stress
  43. Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity
    Marie C. M. Halliez, Jean‐Paul Motta, Troy D. Feener, Gaetan Guérin, Laëtitia Le Goff, Arnaud François, Élodie Colasse, Loïc Favennec, Gilles Gargala, Tamia K. Lapointe et al. · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  44. A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response
    Qian Chen, Yiping Ren, Jihong Lu, Mark Bartlett, Lei Chen, Yan Zhang, Xiaokui Guo, Chang Liu · 2017 · Nutrients
  45. Triggering of proteinase‐activated receptor 4 leads to joint pain and inflammation in mice
    Jason J. McDougall, Chunfen Zhang, Laurie Cellars, Eva Joubert, Chantelle M. Dixon, Nathalie Vergnolle · 2009 · Arthritis & Rheumatism
  46. Visceral pain hypersensitivity in functional gastrointestinal disorders
    Adam Donald Farmer, Qasim Aziz · 2009 · British Medical Bulletin
  47. Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis
    Timo Buhl, Akihiko Ikoma, Cordula Kempkes, Ferda Cevikbas, Mathias Sulk, Joerg Buddenkotte, Tasuku Akiyama, Debbie Crumrine, Eric Camerer, Earl E. Carstens et al. · 2020 · Frontiers in Immunology
  48. Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism
    Dervla O’Malley, Martin Liston, Niall P. Hyland, Timothy G. Dinan, John F. Cryan · 2010 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  49. The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome
    Shawky Abdelhamid Fouad, Maha M. A. Basyoni, Reham A. Fahmy, Mohamed H. Kobaisi · 2011 · Arab Journal of Gastroenterology
  50. Effect of Red Pepper on Symptoms of Irritable Bowel Syndrome: Preliminary Study
    M. Bortolotti, S. Porta · 2011 · Digestive Diseases and Sciences
  51. Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies
    Quigley, Eamonn M.M. · 2011 · Gastroenterology Clinics of North America
  52. Intestinal Exposure to Food-Derived Protease Inhibitors: Digestion Physiology- and Gut Health-Related Effects
    Anna Kårlund, Isa Paukkonen, Carlos Gómez-Gallego, Marjukka Kolehmainen · 2021 · Healthcare
  53. Pathway‐selective antagonism of proteinase activated receptor 2
    Jacky Yung Suen, Adam J. Cotterell, Rink‐Jan Lohman, Junxian Lim, A Han, Mei‐Kwan Yau, Ligong Liu, Matthew A. Cooper, David Alan Vesey, David P. Fairlie · 2014 · British Journal of Pharmacology
  54. Inflammatory bowel disease and irritable bowel syndrome
    Giovanni Barbara, Cesare Cremon, Vincenzo Stanghellini · 2014 · Current Opinion in Gastroenterology
  55. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity
    Annemie Deiteren, Joris G. De Man, Nathalie E. Ruyssers, Tom G. Moreels, Paul A. Pelckmans, Benedicte Y. De Winter · 2014 · Gut
  56. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons
    Barbara Balestra, Riccardo Vicini, Cesare Cremon, Lisa Zecchi, Giovanni Dothel, Valentina I. Vasina, Roberto DE GIORGIO, Alexandro Paccapelo, Ornella Pastoris, Vincenzo Stanghellini et al. · 2012 · Neurogastroenterology & Motility
  57. Peripheral and Central P2X3 Receptor Contributions to Colon Mechanosensitivity and Hypersensitivity in the Mouse
    Masamichi Shinoda, Bin Feng, Gerald F. Gebhart · 2009 · Gastroenterology
  58. Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota
    Ian M. Carroll, Tamar Ringel‐Kulka, Laurent Ferrier, Michael C. Wu, Jennica P. Siddle, Lionel P. Bueno, Yehuda Ringel · 2013 · PLoS ONE
  59. Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury
    Silvio Antoniak, Mauricio Rojas, Denise J. Spring, Tara A. Bullard, Edward D. Verrier, Burns C. Blaxall, Nigel Mackman, Rafał Pawliński · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
  60. Multispecies probiotic protects gut barrier function in experimental models
    Mylène Vivinus-Nébot · 2014 · World Journal of Gastroenterology
  61. Development, plasticity and modulation of visceral afferents
    Christianson, Julie A., Bielefeldt, Klaus, Altier, Christophe, Cenac, Nicolas, Davis, Brian M., Gebhart, Gerald F., High, Karin W., Kollarik, Marian, Randich, Alan, Undem, Brad et al. · 2009 · Brain Research Reviews
  62. Role of mast cell activation in inducing microglial cells to release neurotrophin
    Hongbin Yuan, Xiaoling Zhu, Shuangqiong Zhou, Qianbo Chen, Xiaoxing Zhu, Xue Ma, Xingying He, Mou‐Li Tian, Xueyin Shi · 2009 · Journal of Neuroscience Research
  63. Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase
    Jae Woong Lee, J. Park, D. Park, J. Park, H. Kim, Y. Cho, C. Sohn, W. Jeon, B. I. Kim · 2010 · Digestive Diseases and Sciences
  64. Bacteria: A New Player in Gastrointestinal Motility Disorders—Infections, Bacterial Overgrowth, and Probiotics
    Quigley, Eamonn M.M. · 2007 · Gastroenterology Clinics of North America
  65. Sensory Neurons, Ion Channels, Inflammation and the Onset of Neuropathic Pain
    Patrick L. Stemkowski, Peter A. Smith · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  66. Protease‐activated receptor 2 and gut permeability: a review
    Lionel Buéno, J. Fioramonti · 2008 · Neurogastroenterology and Motility
  67. A novel therapeutic target in various lung diseases: Airway proteases and protease-activated receptors
    Elena Sokolova, Georg Reiser · 2007 · Pharmacology & Therapeutics
  68. Urinary bladder hypersensitivity and dysfunction in female mice following early life and adult stress
    Angela N. Pierce, Elizabeth R. Di Silvestro, Olivia C. Eller, Ruipeng Wang, Janelle M. Ryals, Julie A. Christianson · 2016 · Brain Research
  69. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS
    Giovanni Di Nardo, Giovanni Barbara, Salvatore Cucchiara, Cesare Cremon, Robert Jay Shulman, Sara Isoldi, Lisa Zecchi, Lorenzo Drago, Salvatore Oliva, Rosella Saulle et al. · 2013 · Neurogastroenterology & Motility
  70. Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity
    Nicolas Esquerre, Lilian Basso, Manon Defaye, Fernando Vicentini, Nina L. Cluny, Dominique G. Bihan, Simon Andrew Hirota, Alana Schick, Humberto B. Jijon, Ian A. Lewis et al. · 2020 · Cellular and Molecular Gastroenterology and Hepatology
  71. E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease
    Qiao Yu, Shenghong Zhang, Kang Chao, Rui Feng, Huiling Wang, Manying Li, Baili Chen, Yao He, Zhirong Zeng, Minhu Chen · 2016 · Journal of Crohn s and Colitis
  72. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
    Hannah Ceuleers, Hanne Van Spaendonk, Nikita Hanning, Jelena Heirbaut, Anne‐Marie Lambeir, Jurgen Joossens, Koen Augustyns, Joris G. De Man, Ingrid De Meester, Benedicte Y. De Winter · 2016 · World Journal of Gastroenterology
  73. Active thrombin produced by the intestinal epithelium controls mucosal biofilms
    Jean‐Paul Motta, Alexandre Denadai‐Souza, David Sagnat, Laura Guiraud, Anissa Edir, Chrystelle Bonnart, Mireille Sebbag, Perrine Rousset, Ariane Lapeyre, Carine Séguy et al. · 2019 · Nature Communications
  74. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease – clinical relevance and pathophysiological mechanisms
    Heiko U. De Schepper, Joris G. De Man, Tom G. Moreels, Paul A. Pelckmans, Benedicte Y. De Winter · 2008 · Alimentary Pharmacology & Therapeutics
  75. Downregulation of mucosal mast cell activation and immune response in diarrhoea‐irritable bowel syndrome by oral disodium cromoglycate: A pilot study
    Beatriz Lobo, Laura Ramos, Cristina Martínez, Mar Guilarte, Ana María González-Castro, Carmen Alonso, Marc Pigrau, Inés M. de Torres, Bruno K. Rodiño‐Janeiro, Eloísa Salvo‐Romero et al. · 2017 · United European Gastroenterology Journal
  76. Acupuncture for Visceral Pain: Neural Substrates and Potential Mechanisms
    Shuping Chen, Shubin Wang, Peijing Rong, Junying Wang, Lina Qiao, Xiumei Feng, Junling Liu, Jianliang Zhang · 2014 · Evidence-based Complementary and Alternative Medicine
  77. Probiotics in functional gastrointestinal disorders: what are the facts?
    Eamonn M.M. Quigley · 2008 · Current Opinion in Pharmacology
  78. Regulation of Intestinal Inflammation by Soybean and Soy-Derived Compounds
    Abigail Raffner Basson, Saleh Uddin Mansur Ahmed, Rawan Almutairi, Brian Seo, Fabio Cominelli · 2021 · Foods
  79. Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis
    Ji Yong Ahn, Kyung Hun Lee, Chang Hwan Choi, Ju Wan Kim, Hyun Woong Lee, Jeong Wook Kim, Mi Kyung Kim, Gui Young Kwon, Seungbong Han, Seong‐Eun Kim et al. · 2013 · Digestive Diseases and Sciences
  80. Postinflammatory visceral sensitivity and pain mechanisms
    Nathalie Vergnolle · 2008 · Neurogastroenterology & Motility
  81. Neurotrophic Factors and Nociceptor Sensitization
    Michael P. Jankowski, H. Richard Koerber · 2009 · Frontiers in neuroscience
  82. Novel therapeutic targets for enteric nervous system disorders
    Roberto DE GIORGIO, G BARBARA, John B. Furness, Marcello Tonini · 2007 · Trends in Pharmacological Sciences
  83. Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria
    Sessenwein, Jessica L., Baker, Corey C., Pradhananga, Sabindra, Maitland, Megan E., Petrof, Elaine O., Allen-Vercoe, Emma, Noordhof, Curtis, Reed, David E., Vanner, Stephen J., Lomax, Alan E. · 2017 · The Journal of Neuroscience
  84. Epidemiological and Molecular Characterization of Blastocystis Infection in Children Attending Daycare Centers in Medellín, Colombia
    María Isabel Osorio‐Pulgarín, Adriana Higuera, Juan Camilo Beltrán-Alzate, Miryan Margot Sánchez‐Jiménez, Juan David Ramírez · 2021 · Biology
  85. Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract
    Keith A. Sharkey, Tor Savidge · 2013 · Autonomic Neuroscience
  86. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer
    Morley Donald Hollenberg, Κατερίνα Οικονομοπούλου, Kristina K. Hansen, Mahmoud Saifeddine, Rithwik Ramachandran, Eleftherios P. Diamandis · 2008 · Biological Chemistry
  87. Gastrointestinal Parasites and the Neural Control of Gut Functions
    Marie C. M. Halliez, André G. Buret · 2015 · Frontiers in Cellular Neuroscience
  88. Parasites, nutrition, immune responses and biology of metabolic tissues
    Terez Shea‐Donohue, Bolin Qin, Allen D. Smith · 2017 · Parasite Immunology
  89. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators
    Martin‐Viñas, Juan J, Quigley, Eamonn M M · 2016 · Journal of Digestive Diseases
  90. Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients
    Shahram Khademvatan, Rahim Masjedizadeh, Fakher Rahim, Hamidreza Mahbodfar, Roya Salehi Kahyesh, Ehsan Yousefi-Razin, Masoud Foroutan · 2017 · Parasitology International
  91. Human visceral afferent recordings: preliminary report
    Madusha Peiris, David Colin Bulmer, Mark D. Baker, George Boundouki, Sidhartha Sinha, Anthony Robert Hobson, Kevin Lee, Qasim Aziz, Charles H. Knowles · 2010 · Gut
  92. Celiac disease: should we care about microbes?
    Alberto Caminero, Elena Francisca Verdu · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  93. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state
    Dipti V. Tillu, Shayne N. Hassler, C. Burgos-Vega, Tammie L. Quinn, Robert E. Sorge, Gregory O. Dussor, Scott A. Boitano, Josef Vágner, Theodore John Price · 2015 · Pain
  94. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions.
    D Grundy · 2008 · PubMed
  95. Intestinal neuro-immune interactions: focus on macrophages, mast cells and innate lymphoid cells
    Nathalie Stakenborg, Maria Francesca Viola, Guy E. Boeckxstaens · 2019 · Current Opinion in Neurobiology
  96. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome
    Yasmin Nasser, Guy E. Boeckxstaens, Mira M. Wouters, Michael Schemann, Stephen J. Vanner · 2014 · Neurogastroenterology & Motility
  97. Modulation of Meningeal Nociceptors Mechanosensitivity by Peripheral Proteinase-Activated Receptor-2: The Role of Mast Cells
    X-C Zhang, Dan Levy · 2008 · Cephalalgia
  98. Characterization of two cysteine proteases secreted by Blastocystis ST7, a human intestinal parasite
    Ivan Wawrzyniak, Catherine Texier, Philippe Poirier, Éric Viscogliosi, Kevin S. W. Tan, Frédéric Delbac, Hicham El Alaoui · 2012 · Parasitology International
  99. Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists
    Luis R. Gardell, Jian‐Nong Ma, Jimmi Gerner Seitzberg, Anne Eeg Knapp, Hans H. Schiffer, Ali Tabatabaei, Christopher N. Davis, Michelle Owens, Bryan Clemons, Kenneth K. Wong et al. · 2008 · Journal of Pharmacology and Experimental Therapeutics
  100. Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use
    José Antonio Uranga, Vicente Martı́nez, Raquel Abalo · 2020 · Molecules